Case 2Prostaglandin periostitisCase 3Prostaglandin periostitisCase 4Prostaglandin periostitis
History: 27-day-old female with a congenital heart defect (DORV, VSD)
Findings
Diffuse periosteal bone formation.
Differential
Prostaglandin periostitis
Physiologic periostitis
Trauma
Caffey's disease
Congenital syphilis
Hypervitaminosis A
Scurvy
Hypertrophic osteoarthropathy
Leukemia
Skeletal metastasis
Impression
Prostaglandin periostitis
Discussion
Prostaglandin E1 is commonly used to maintain a patent ductus arteriosus in patients with ductus-dependent congenital heart disease.
Periosteal bone formation is usually seen with long-term prostaglandin treatment (>40 days), but can be seen with short-term therapy with prostaglandin E2 (9-14 days).
Symmetrical distribution is not always present.
Generally self-limited with no effect on subsequent bone growth and development.
Complete resolution common in 6 months to 1 year.
History: 25 day old male with Tetralogy of Fallot
Findings
Diffuse periosteal bone reaction
Cardiomegaly and boot-shaped heart consistent with the provided history of Tetralogy of Fallot
Differential
Prostaglandin periostitis
Physiologic periostitis
Trauma
Caffey's disease
Congenital syphilis
Hypervitaminosis A
Scurvy
Hypertrophic osteoarthropathy
Leukemia
Skeletal metastasis
Impression
Prostaglandin periostitis
Discussion
Prostaglandin E1 is commonly used to maintain a patent ductus arteriosus in patients with ductus-dependent congenital heart disease (such as TOF in this case).
Periosteal bone formation is usually seen with long-term prostaglandin treatment (>40 days), but can be seen with short-term therapy with prostaglandin E2 (9-14 days).
Symmetrical distribution is not always present.
Generally self-limited with no effect on subsequent bone growth and development.
Complete resolution common in 6 months to 1 year.
History: 3-month-old female with a ventricular septal defect
Findings
Periosteal reaction involving the left humerus, scapula, and ulna.
Differential
Prostaglandin periostitis
Physiologic periostitis
Trauma
Caffey's disease
Congenital syphilis
Hypervitaminosis A
Scurvy
Hypertrophic osteoarthropathy
Leukemia
Skeletal metastasis
Impression
Prostaglandin periostitis
Discussion
Prostaglandin E1 is commonly used to maintain a patent ductus arteriosus in patients with ductus-dependent congenital heart disease.
Periosteal bone formation is usually seen with long-term prostaglandin treatment (>40 days), but can be seen with short-term therapy with prostaglandin E2 (9-14 days).
Symmetrical distribution is not always present (as in this case)
Generally self-limited with no effect on subsequent bone growth and development.
Complete resolution common in 6 months to 1 year.
History: 2 month old male with Tetralogy of Fallot
Findings
Diffuse periosteal bone formation involving the femur, tibia, and fibula
Differential
Prostaglandin periostitis
Physiologic periostitis
Trauma
Caffey's disease
Congenital syphilis
Hypervitaminosis A
Scurvy
Hypertrophic osteoarthropathy
Leukemia
Skeletal metastasis
Impression
Prostaglandin periostitis
Discussion
Prostaglandin E1 is commonly used to maintain a patent ductus arteriosus in patients with ductus-dependent congenital heart disease (such as TOF in this case)
Periosteal bone formation is usually seen with long-term prostaglandin treatment (>40 days), but can be seen with short-term therapy with prostaglandin E2 (9-14 days)
Symmetrical distribution is not always present.
Generally self-limited with no effect on subsequent bone growth and development.